Weetabix should pass painlessly through A&E despite increased sterling swap costs

Lenders to Lion Capital’s cereal maker Weetabix expect the firm’s amend and extend request to be approved, after 50% of the syndicate accepted the terms on offer during a pre-sounding. Investors said that the margin uplift on offer should be enough to offset increased euro-sterling swap costs.